BindingDB logo
myBDB logout

BDBM229994 US9556135, 104

SMILES: CC1(C)C(N)=N[C@@](C)(CS1(=O)=O)c1cc(Nc2ncnc3cc(OCC4CC4)cnc23)ccc1F

InChI Key: InChIKey=AQKBNJGDNOKVKN-DEOSSOPVSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 229994   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cathepsin D


(Homo sapiens (Human))
BDBM229994
PNG
(US9556135, 104)
Show SMILES CC1(C)C(N)=N[C@@](C)(CS1(=O)=O)c1cc(Nc2ncnc3cc(OCC4CC4)cnc23)ccc1F |r,c:4|
Show InChI InChI=1S/C24H27FN6O3S/c1-23(2)22(26)31-24(3,12-35(23,32)33)17-8-15(6-7-18(17)25)30-21-20-19(28-13-29-21)9-16(10-27-20)34-11-14-4-5-14/h6-10,13-14H,4-5,11-12H2,1-3H3,(H2,26,31)(H,28,29,30)/t24-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.58E+5n/an/an/an/a3.5n/a



Amgen, Inc.

US Patent


Assay Description
Recombinant Cat D was expressed in CHO cells. The assay buffer for CathepsinD is 0.05 M citrate pH 3.5, 10% DMSO final, 5 mM CHAPS. The Cat D enzyme ...


US Patent US9556135 (2017)


BindingDB Entry DOI: 10.7270/Q2X0691F
More data for this
Ligand-Target Pair
Beta-secretase 1


(Homo sapiens (Human))
BDBM229994
PNG
(US9556135, 104)
Show SMILES CC1(C)C(N)=N[C@@](C)(CS1(=O)=O)c1cc(Nc2ncnc3cc(OCC4CC4)cnc23)ccc1F |r,c:4|
Show InChI InChI=1S/C24H27FN6O3S/c1-23(2)22(26)31-24(3,12-35(23,32)33)17-8-15(6-7-18(17)25)30-21-20-19(28-13-29-21)9-16(10-27-20)34-11-14-4-5-14/h6-10,13-14H,4-5,11-12H2,1-3H3,(H2,26,31)(H,28,29,30)/t24-/m0/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.54n/an/an/an/an/an/a



Amgen, Inc.

US Patent


Assay Description
Several animal models, including mouse, rat, dog, and monkey, may be used to screen for inhibition of beta-secretase activity in vivo following admin...


US Patent US9556135 (2017)


BindingDB Entry DOI: 10.7270/Q2X0691F
More data for this
Ligand-Target Pair